RBM45 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.689900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.605800E-01
Normal-vs-Stage2
5.328100E-02
Normal-vs-Stage3
6.297600E-02
Normal-vs-Stage4
7.850400E-01
Stage1-vs-Stage2
5.745000E-01
Stage1-vs-Stage3
1.786810E-01
Stage1-vs-Stage4
4.850200E-01
Stage2-vs-Stage3
1.505010E-01
Stage2-vs-Stage4
1.084240E-01
Stage3-vs-Stage4
1.439780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.400300E-02
Normal-vs-AfricanAmerican
1.039570E-01
Normal-vs-Asian
7.728100E-02
Caucasian-vs-AfricanAmerican
8.591200E-01
Caucasian-vs-Asian
3.039800E-01
AfricanAmerican-vs-Asian
6.411600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.489700E-02
Normal-vs-Female
8.807600E-02
Male-vs-Female
4.765600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.805200E-01
Normal-vs-Age(41-60Yrs)
9.938200E-02
Normal-vs-Age(61-80Yrs)
4.706100E-02
Normal-vs-Age(81-100Yrs)
1.036240E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.641400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.653600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.072600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.144200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.269800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.175000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.128100E-02
Normal-vs-Daily Drinker
9.592500E-02
Normal-vs-Weekly Drinker
5.493500E-02
Normal-vs-Occasional Drinker
1.502440E-01
Normal-vs-Social Drinker
1.456400E-01
Non Drinker-vs-Daily Drinker
9.536800E-01
Non Drinker-vs-Weekly Drinker
8.289600E-01
Non Drinker-vs-Occasional Drinker
4.074200E-02
Non Drinker-vs-Social Drinker
3.825800E-01
Daily Drinker-vs-Weekly Drinker
8.909400E-01
Daily Drinker-vs-Occasional Drinker
5.963600E-02
Daily Drinker-vs-Social Drinker
4.289000E-01
Weekly Drinker-vs-Occasional Drinker
3.832200E-02
Weekly Drinker-vs-Social Drinker
3.465400E-01
Occasional Drinker-vs-Social Drinker
3.334000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.649170E-01
Normal-vs-Grade 2
4.861600E-01
Normal-vs-Grade 3
3.395800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.232300E-02
Grade 1-vs-Grade 3
1.719660E-02
Grade 1-vs-Grade 4
1.649170E-01
Grade 2-vs-Grade 3
3.843400E-01
Grade 2-vs-Grade 4
4.861600E-01
Grade 3-vs-Grade 4
3.395800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.240000E-02
Normal-vs-NonDiabetic
3.760000E-02
Diabetic-vs-NonDiabetic
4.850400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.573900E-02
Normal-vs-NoPancreatitis
5.040000E-02
Pancreatitis-vs-NoPancreatitis
3.866800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.083810E-01
Normal-vs-N1
4.674200E-02
N0-vs-N1
6.316800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.030000E-01
Normal-vs-TP53-NonMutant
1.356800E-01
TP53-Mutant-vs-TP53-NonMutant
3.180500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
